Home LiteratureArticle Details
PMID: 3194021 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3' AU-rich sequences.

Nature ·Vol. 336 ·No. 6197 ·1988-11-24 ·Pages 396-9

Wilson T, Treisman R

Abstract

The c-fos proto-oncogene provides a good system to study the processes underlying messenger RNA degradation. After growth factor stimulation of susceptible cells, the c-fos transcription rate transiently increases from a low basal level by as much as 50-fold, producing a large amount of exceedingly unstable c-fos mRNA that is rapidly degraded. Here, we investigate the c-fos mRNA degradation process, and find that: (1) ongoing translation of the c-fos mRNA itself is required for its degradation; (2) after synthesis, the mRNA poly(A) tail is rapidly removed, in a translation-dependent manner, leading to accumulation of apparently deadenylated RNA; (3) deletion or replacement of an AU-rich sequence at the mRNA 3' end significantly stabilizes the mRNA; (4) deletion of the 3' AU-rich sequences dramatically slows the poly(A) shortening rate. These results suggest that the 3' AU-rich sequences act to destabilize the mRNA by directing rapid removal of the mRNA poly(A) tract.

MeSH Terms
Base Sequence Molecular Sequence Data Poly A/metabolism Protein Biosynthesis Proto-Oncogenes RNA Probes RNA, Messenger/metabolism
Chemicals
RNA Probes RNA, Messenger Poly A
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Wilson T
MRC Laboratory of Molecular Biology, MRC Centre, Cambridge, UK.
Treisman R
Article Info
Journal
Nature
Abbr.
Nature
ISSN
0028-0836
Published
1988-11-24
Pages
396-9
Language
English
Region
England
NLM ID
0410462
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com